Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
ACS Chem Biol ; 12(8): 2201-2208, 2017 08 18.
Artigo em Inglês | MEDLINE | ID: mdl-28687042

RESUMO

The selective reaction of chemical reagents with reduced protein thiols is critical to biological research. This reaction is utilized to prevent cross-linking of cysteine-containing peptides in common proteomics workflows and is applied widely in discovery and targeted redox investigations of the mechanisms underlying physiological and pathological processes. However, known and commonly used thiol blocking reagents like iodoacetamide, N-ethylmaleimide, and others were found to cross-react with oxidized protein sulfenic acids (-SOH) introducing significant errors in studies employing these reagents. We have investigated and are reporting here a new heteroaromatic alkylsulfone, 4-(5-methanesulfonyl-[1,2,3,4]tetrazol-1-yl)-phenol (MSTP), as a selective and highly reactive -SH blocking reagent compatible with biological applications.


Assuntos
Descoberta de Drogas , Fenóis/química , Sulfonas/química , Tetrazóis/química , Linhagem Celular Tumoral , Membrana Celular/efeitos dos fármacos , Humanos , Espectrometria de Massas , Modelos Biológicos , Estrutura Molecular , Reagentes de Sulfidrila/química , Reagentes de Sulfidrila/farmacocinética , Reagentes de Sulfidrila/farmacologia , Sulfonas/farmacocinética , Sulfonas/farmacologia
2.
J Neurosci ; 21(12): 4162-72, 2001 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-11404401

RESUMO

In AMPA receptor channels, a single amino acid residue (Q/R site) of the M2 segment controls permeation of calcium ions, single-channel conductance, blockade by intracellular polyamines, and permeation of anions. The structural environment of the Q/R site and its positioning with regard to a narrow constriction were probed with the accessibility of substituted cysteines to positively and negatively charged methanethiosulfonate reagents, applied from the extracellular and cytoplasmic sides of the channel. The accessibility patterns confirm that the M2 segment forms a pore loop with the Q/R site positioned at the tip of the loop (position 0) facing the extracellular vestibule. Cytoplasmically accessible residues on the N- and C-terminal sides of position 0 form the ascending alpha-helical (-8 to -1) and descending random coil (+1 to +6) components of the loop, respectively. Substitution of a glycine residue at position +2 with alanine strongly decreased the permeability of organic cations, indicating that position +2 contributes to the narrow constriction. The anionic 2-sulfonatoethyl-methanethiosufonate reacted with a cysteine at position 0 only from the external side and with cysteines at positions +1 to +4 only from the cytoplasmic side. These results suggest that charge selectivity occurs external to the constriction (+2) and possibly involves interactions of ions with the negative electrostatic potential created by the dipole of the alpha-helix formed by the ascending limb of the loop.


Assuntos
Ativação do Canal Iônico/fisiologia , Receptores de AMPA/metabolismo , Substituição de Aminoácidos , Animais , Cálcio/metabolismo , Cisteína/química , Cisteína/efeitos dos fármacos , Cisteína/genética , Citoplasma/metabolismo , Relação Dose-Resposta a Droga , Metanossulfonato de Etila/análogos & derivados , Metanossulfonato de Etila/química , Metanossulfonato de Etila/farmacocinética , Ácido Glutâmico/farmacologia , Ativação do Canal Iônico/efeitos dos fármacos , Ácido Caínico/farmacologia , Cinética , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Mesilatos/química , Mesilatos/farmacocinética , Microinjeções , Mutagênese Sítio-Dirigida , Oócitos/efeitos dos fármacos , Oócitos/metabolismo , Técnicas de Patch-Clamp , Permeabilidade/efeitos dos fármacos , Receptores de AMPA/genética , Relação Estrutura-Atividade , Reagentes de Sulfidrila/química , Reagentes de Sulfidrila/farmacocinética , Xenopus laevis
3.
J Enzyme Inhib ; 14(5): 381-90, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-10488248

RESUMO

Human 'electron transferring flavoprotein' (ETF) was inactivated by the thiol-specific reagent 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB). The kinetic profile showed the reaction followed pseudo-first-order kinetics during the initial phase of inactivation. Monitoring the release of 5-thio-2-nitrobenzoate (TNB) showed that modification of 1 cysteine residue was responsible for the loss of activity. The inactivation of ETF by DTNB could be reversed upon incubation with thiol-containing reagents. The loss of activity was prevented by the inclusion of medium chain acyl-CoA dehydrogenase (MCAD) and octanoyl-CoA. Cyanolysis of the DTNB modified-ETF with KCN led to the release of TNB accompanied presumably by the formation of the thio-cyano enzyme and with almost full recovery of activity. Conservation studies and the lack of 100% inactivation, however, suggested that this cysteine residue is not essential for the interaction with MCAD.


Assuntos
Acil-CoA Desidrogenases/química , Acil-CoA Desidrogenases/metabolismo , Cisteína/química , Ácido Ditionitrobenzoico/análise , Flavoproteínas/metabolismo , Acil-CoA Desidrogenase , Sítios de Ligação , Biomarcadores/análise , Transporte de Elétrons , Flavoproteínas Transferidoras de Elétrons , Flavoproteínas/antagonistas & inibidores , Humanos , Cinética , Sondas Moleculares , Ligação Proteica , Reagentes de Sulfidrila/farmacocinética
4.
Toxicology ; 103(2): 105-12, 1995 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-8545842

RESUMO

Forty C57 BL/6J mice, injected subcutaneously with 0.5 mg/kg arsenic as sodium arsenite, were examined for 24-h urinary excretion of total arsenic metabolites, creatinine and S-adenosylmethionine (SAM) and for 24-h faecal excretion of arsenic and levels of arsenic in the blood, liver, kidneys, lung, skin, spleen and bone at 24-h post-dose. Total urinary arsenic metabolites were calculated by summing up the inorganic (Asi), monomethylated (MMA) and dimethylated (DMA) derivatives directly measured by selective arsine generation-atomic absorption spectrometry (AG-AAS) or were measured by AG-AAS following complete mineralization. Both sets of results showed interindividual differences varying by as much as 7-fold and correlated with the 24-h urinary excretion of both SAM (r = 0.84 and r = 0.86, respectively) and creatinine (r = 0.82 and r = 0.87, respectively). There was interindividual variability of about a 30-fold range in 24-h faecal excretion of arsenic which correlated inversely with 24-h urinary excretion of arsenic metabolites (r = -0.69) and 24-h urinary excretion of both creatinine (r = -0.70) and SAM (r = -0.67). Body tissue levels of arsenic were low and not related to 24-h urinary excretion of arsenic metabolites, SAM and creatinine. Taken together, the results indicate that differences in the profile of urinary arsenic excretion and in the retention of arsenic in a particular organ do not contribute to interindividual variability in 24-h urinary excretion of arsenic metabolites by C57 BL/6J mice, but that variability in faecal excretion does, at least in part. It is speculated that there is most likely a predominant contribution from a diffuse tissue retention of arsenic or from a third route of arsenic elimination, i.e. respiratory, to this phenomenon in view of the small faecal contribution.


Assuntos
Arsênio/urina , Arsenitos/farmacocinética , Compostos de Sódio/farmacocinética , Reagentes de Sulfidrila/farmacocinética , Animais , Arsênio/sangue , Arsênio/metabolismo , Arsenitos/administração & dosagem , Arsenitos/toxicidade , Osso e Ossos/efeitos dos fármacos , Osso e Ossos/metabolismo , Creatinina/urina , Fezes/química , Injeções Subcutâneas , Rim/efeitos dos fármacos , Rim/metabolismo , Fígado/efeitos dos fármacos , Fígado/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Músculos/efeitos dos fármacos , Músculos/metabolismo , Padrões de Referência , Reprodutibilidade dos Testes , S-Adenosilmetionina/urina , Pele/efeitos dos fármacos , Pele/metabolismo , Compostos de Sódio/administração & dosagem , Compostos de Sódio/toxicidade , Espectrofotometria Atômica , Baço/efeitos dos fármacos , Baço/metabolismo , Reagentes de Sulfidrila/administração & dosagem , Reagentes de Sulfidrila/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA